Application 204824
- Type
- NDA
- Sponsor
- ANTARES PHARMA INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OTREXUP | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 10MG/0.4ML (10MG/0.4ML) | Yes | Yes |
| 002 | OTREXUP | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 15MG/0.4ML (15MG/0.4ML) | Yes | Yes |
| 003 | OTREXUP | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 20MG/0.4ML (20MG/0.4ML) | Yes | Yes |
| 004 | OTREXUP | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 25MG/0.4ML (25MG/0.4ML) | Yes | Yes |
| 005 | OTREXUP | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 7.5MG/0.4ML (7.5MG/0.4ML) | Yes | No |
| 006 | OTREXUP | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 12.5MG/0.4ML (12.5MG/0.4ML) | Yes | Yes |
| 007 | OTREXUP | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 17.5MG/0.4ML (17.5MG/0.4ML) | Yes | Yes |
| 008 | OTREXUP | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 22.5MG/0.4ML (22.5MG/0.4ML) | Yes | Yes |
| 009 | OTREXUP PFS | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 10MG/0.4ML (10MG/0.4ML) | Yes | No |
| 010 | OTREXUP PFS | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 15MG/0.6ML (15MG/0.6ML) | Yes | No |
| 011 | OTREXUP PFS | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 17.5MG/0.7ML (17.5MG/0.7ML) | Yes | No |
| 012 | OTREXUP PFS | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 20MG/0.8ML (20MG/0.8ML) | Yes | No |
| 013 | OTREXUP PFS | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 22.5MG/0.9ML (22.5MG/0.9ML) | Yes | No |
| 014 | OTREXUP PFS | METHOTREXATE | SOLUTION;SUBCUTANEOUS | 25MG/ML (25MG/ML) | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 54436-010 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-010 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-010 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-010 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-010 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-010 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-012 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-012 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-012 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-012 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-012 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-012 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-015 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-015 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-015 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-015 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-015 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-015 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-017 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-017 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-017 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-017 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-017 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-017 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-020 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-020 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-020 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-020 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-020 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-020 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-022 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-022 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-022 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-022 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-022 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-022 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-025 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-025 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-025 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-025 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-025 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |
| 54436-025 | Otrexup | methotrexate | Antares Pharma, Inc. | NDA | Current |